MedTrace Logo

The Effect of Platelet-rich Plasma Nasal Injection in the Treatment of Traumatic Olfactory Dysfunction

NCT06290219 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-03-04

No results posted yet for this study

Summary

The purpose of this study is to explore the efficacy of injecting high-concentration platelet plasma combined with hyaluronic acid into the nasal olfactory mucosa in the treatment of traumatic anosmia.

Conditions

  • Traumatic Olfactory Nerve Injury With Anosmia (Diagnosis)
  • Effect of Drug

Interventions

COMBINATION_PRODUCT

platelet-rich plasma combined with hyaluronic acid

The project investigator injects plasma mixed with hyaluronic acid into the nasal septum and the medial side of the middle turbinate of the patient's nasal cavity under a nasal endoscope.

DRUG

Zinc Gluconate 10 MG Oral Tablet

one tablet three times a day for a period of 12 weeks

DEVICE

4 bottles of phenyl ethyl alcohol, lemon, eucalyptus, and clove oil

Sniffing each odorant for 10 seconds, twice a day for 12 weeks

Sponsors & Collaborators

  • Taichung Veterans General Hospital

    lead OTHER

Principal Investigators

  • Rong-San Jiang, MD, PhD · Taichung Veterans General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-20
Primary Completion
2024-09-30
Completion
2024-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06290219 on ClinicalTrials.gov